New DBS device for Parkinson’s approved for US patients

News

Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story

Comments


Related articles


SURVEY-2016-lead

Global update

Take the Parkinson’s Life survey for a chance to win!

Parkinson’s Life 2016 Survey: tell us what you think

READ MORE
Parkinson's news

Global update

Parkinson’s in the news: August

A roundup of Parkinson’s news stories in August

READ MORE
Rosemary maguire

Perspectives

Leading campaigners pay tribute to pioneering Parkinson’s nurse

Praising the “huge contribution” of late Parkinson’s specialist nurse

READ MORE